Article

Medaka liver developed Human NAFLD-NASH transcriptional signatures in response to ancestral bisphenol A exposure

2024-07-16

Abstract excerpt

<title>Abstract</title> <p>The progression of fatty liver disease to non-alcoholic steatohepatitis (NASH) is a leading cause of death in humans. Lifestyles and environmental chemical exposures can increase the susceptibility of humans to NASH. In humans, the presence of bisphenol A (BPA) in urine is associated with fatty liver disease, but whether ancestral BPA exposure leads to the activation of human NAFLD-NASH...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 1d3e4aa0-e09a-5d76-a620-b893c9aeb762
DOI: 10.21203/rs.3.rs-4585175/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Medaka liver developed Human NAFLD-NASH transcriptional signatures in response to ancestral bisphenol A exposureDOI 10.21203/rs.3.rs-4585175/v1Read

Sex-specific expression of the human NAFLD-NASH transcriptional signatures in the liver of medaka with a history of ancestral bisphenol A exposureSemantic proximity Read

The PCOS-NAFLD Multidisease Phenotype Occurred in Medaka Fish Four Generations after the Removal of Bisphenol A Exposure.Semantic proximity Read

Stable Transmission of DNA Methylation Epimutations from Germlines to the Liver and Their Association with Fatty Liver Disease in MedakaSemantic proximity Read

Comprehensive analysis of epigenetic and epitranscriptomic genes’ expression in human NAFLDSemantic proximity Read

Sex differences in the progression from NAFL to NASH: a functional meta-analysis of transcriptomic studiesSemantic proximity Read

Comparative Analysis of Global Hepatic Gene Expression in Adolescents and Adults with Non-alcoholic Fatty Liver DiseaseSemantic proximity Read

Genetic and epigenetic mechanisms of NASH.Semantic proximity Read

Epigenetic Mechanisms Underlying the Link between Non-Alcoholic Fatty Liver Diseases and NutritionSemantic proximity Read

Personalized therapy when tackling nonalcoholic fatty liver disease: a focus on sex, genes, and drugs.Semantic proximity Read

A network-based approach reveals the dysregulated transcriptional regulation in non-alcohol fatty liver diseaseSemantic proximity Read

Epigenetics in NAFLD/NASH: Targets and therapySemantic proximity Read

Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individualsSemantic proximity Read